Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients
Abstract Although immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) patients, a significant proportion of responders still experience progressive disease after a period of response. Limited data are available on the clinical patterns of acquired r...
Guardado en:
Autores principales: | Ja Yoon Heo, Shin Hye Yoo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6baa071334004d26bec6ff48566948c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: So Yeon Oh, et al.
Publicado: (2021) -
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
por: Chan-Young Ock, et al.
Publicado: (2017) -
Durability and Self-healing Effects of Hydrogel Coatings with respect to Contact Condition
por: Chang-Lae Kim, et al.
Publicado: (2017) -
Effect of Deformation Structure of AISI 316L in Low-Temperature Vacuum Carburizing
por: Hyunseok Cheon, et al.
Publicado: (2021) -
Developmental features and predicting airway failure risk in critically ill children with mandibular hypoplasia using 3D computational tomographic analysis
por: Doo-Hwan Kim, et al.
Publicado: (2021)